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Background
==========

Babesiosis is a typical zoonotic disease which is caused by *Babesia* spp*.*, tick-borne intraerythrocytic protozoan parasites. The first definitive case of human babesiosis, was documented in a Yugoslavian farmer in 1957 \[[@B1]\]. The first case in an immunocompetent person was identified on Nantucket Island, off the coast of Massachusetts, in 1969 \[[@B2]\]. In fact, the causative agent was *Babesia microti*, and the vector was the *Ixodes dammini* tick (now referred to as *I. scapularis*) \[[@B3]\]. Babesiosis is now classified as a notifiable disease and is recognized as an emerging health risk in several parts of the world \[[@B4]\], but little is known about the its prevalence in malaria-endemic countries, where misidentification as *Plasmodium* spp. probably  occurs  (<http://dpd.cdc.gov/dpdx/HTML/Babesiosis.htm>). In Asia, *B. microti*-like organisms have caused illness in Japan, Taiwan, and mainland China \[[@B5]-[@B8]\]. In Europe, a few human babesiosis cases have been attributed to *B. divergens*, the cattle species transmitted by *I. ricinus*\[[@B9]-[@B11]\]. Hundreds of human babesiosis cases in the northeast and midwest United States have been attributed to *B. microti*\[[@B12]\]*.* Sporadic cases of babesiosis have been reported in Africa, Australia, and South America \[[@B9],[@B13],[@B14]\].

Recently, co-infection of parasites in humans has been noticed in many areas \[[@B15]-[@B17]\]. Human babesiosis has sometimes been diagnosed initially as malaria because of the similarity between the two diseases or the two parasites \[[@B18],[@B19]\]. Thus, it is likely that cases of human babesiosis in countries in which malaria is endemic have been overlooked or misdiagnosed as malaria. The area along the China-Myanmar border in Yunnan has been reported as a main endemic area of malaria in the People's Republic of China (P.R. China) \[[@B20],[@B21]\], however *B. microti* has not been recognized as being endemic in this region in the past. Therefore, surveillance was carried out between April 2012 and June 2013 on the presence of *B. microti* from the patients' blood as detected by molecular tools collected in this area.

Methods
=======

Study area and population
-------------------------

The area along the China-Myanmar border in Yunnan is a main endemic area of malaria in China. The region is hilly and covered largely by primary and secondary rainforests. Inhabitants of the division are mainly rural indigenous people. Besides working for the logging industry in the surrounding jungles, inhabitants of the Tengchong county in the Yunnan province are actively involved in mining, farming, hunting, logging, and working abroad in Myanmar but coming back frequently. The population of the Tengchong county is served by a general hospital, a polyclinic at the county's Center for Disease Control and Prevention (CDC), and 15 government health clinics.

The study was reviewed and approved by the Ethics Committee at the National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention. Four hundred and forty-nine blood samples in people with malaria-like symptoms were obtained between April 2012 and June 2013 in the area along the China-Myanmar border in the Yunnan province of China. Written consent was obtained from each person before blood samples were obtained.

Blood samples
-------------

This survey was carried out on the population seeking care at the Tengchong county CDC. During the study period, finger-prick blood samples on filter paper from 449 febrile patients with malaria-like symptoms were taken. The thick and thin blood films were stained with Giemsa and examined by staff at the diagnostic laboratories of the polyclinic and hospital.

A drop (20 μL-50 μL) of blood was placed directly on a pre-marked filter paper. DNA was extracted from the blood spots with QIAGEN (QIAamp DNA Blood Mini Kit, Biosearch Technologies, Inc. USA) and all of the positive samples were used for sequencing the small subunit ribosomal RNA (SSU rRNA) of the parasites.

SSU rRNA Sequence and phylogenetic analysis
-------------------------------------------

After the screening of *Plasmodium* spp. infection by microscopy, all the samples' DNA templates for a nested polymerase chain reaction (PCR) were prepared from whole blood spots on the filter paper. Two microliters of PCR product from each, amplified by *Plasmodium* genus-specific primer pair rPLU1 and rPLU5, were subjected to a second PCR amplification with species-specific primer pairs rVIV1 and rVIV2 for *P. vivax*, rFAL1 and rFAL2 for *P. falciparum*, rMAL1 and rMAL2 for *P. malariae*, and rOVA1 and rOVA2 for *P. ovale*\[[@B22]\]. *B. microti*-specific fragments of SSU rRNA were amplified from the DNA extracted from all the febrile patients by nested PCR with two sets of *B. microti*-specific primers, Bab1-Bab4, and Bab2-Bab3 (*B. microti* detection PCR), in accordance with the method established by Persing *et al.*\[[@B23]\]. For *B. microti* detection PCR-positive samples, a more accurate analysis by amplification of the full-sized sequence (\~1.7 kb) encoding the 18S rRNA gene of the *Babesia* parasite from the patients was applied with the nested PCR primers to confirm the infections. The first round primers were Piro1F: 5'-CCATGCATGTCTWAGTAYAARCTTTTA-3' and rRNA-3': 5'-ATCCTTCYGCAGGTTCACCTAC-3'. The second round primers were BablA: 5'-GTCTTAGTATAAGCTTTTATACAGCG-3' and Prio6R: 5'-CTCCTTCCTY TAAGTGATAAGGTTCAC-3', as described by Medlin *et al.*\[[@B24],[@B25]\]. PCR amplification for each sample was done in a 50 μL reaction mixture containing 400 mM each of deoxynucleoside triphosphates, 0.25 mM of primer, ten to 100 ng of template DNA, and 2.5 U of Taq DNA polymerase (TIANGEN Biochemical) in 50 ml of the PCR buffer supplied together with the enzyme. PCR amplification parameters were: 94°C for four minutes, 35 cycles at 94°C for 30 seconds, 55°C for one minute and 72°C for 2 min, followed by a final extension for ten minutes at 72°C. PCR products amplified with nested primers were analyzed by agarose gelelectrophoresis. DNA bands were removed from the gel, purified by using the QIAquick Gel Extraction Kit (QIAGEN, Valencia, CA, USA), and ligated to T-cloning vector (Invitrogen, Carlsbad, CA, USA) according to protocols provided by the manufacturers.

To avoid errors caused by contamination of PCR products, DNA was extracted and divided into several aliquots in a safety cabinet placed in a room in which PCR products had never been treated. Detection and confirmation of PCR assays were separately carried out with the different aliquots.

Plasmid inserts were then sequenced. Sequence identity was confirmed by random basic local alignment search tool analysis of sequences in GenBank (<http://blast.ncbi.nlm.nih.gov/>). Phylogenetic relationships of unique sequences amplified were constructed by using the neighbor-joining method using MegAlign software (DNASTAR, Inc. Madison, WI, USA).

Results
=======

Detection of B. *microti* and *Plasmodium* spp
----------------------------------------------

Four species of parasites taking residence in human erythrocyte (*B. microti, P. falciparum*, *P. vivax,* and *P. malariae*) were identified in 449 suspected febrile persons. Mono-infection with *B. microti, P. vivax*, *P. falciparum*, or *P. malariae* accounted for 1.8% (8/449), 9.8% (44/449), 2.9% (13/449), and 0.2% (1/449), respectively, of the total infections. The rate of mixed infections of *B. microti* and *P. falciparum* or *P. vivax* were both 0.2% (1/449), and mixed infections of *P. falciparum* and *P. vivax* accounted for 1.1% (5/449) (see Table [1](#T1){ref-type="table"} and Figure [1](#F1){ref-type="fig"}). The total prevalence of *B. microti* was 2.2% (10/449). One *P. falciparum* mono-infection case, five *P. vivax*, and eight *B. microti* cases were detected from microscopy screening negative samples. Two mixed infection cases of *B. microti* co-infection with *P. falciparum* or *P. vivax* were initially diagnosed as mono-infections of *Plasmodium* spp*.* by microscopy screening.

###### 

***B. microti*and*Plasmodium*spp. detection in 449 suspected febrile patients in the area along the China-Myanmar border in the Yunnan province between April 2012 and June 2013**

  **Parasite**                     **No. (%) persons**
  ------------------------------ ---------------------
  *B. microti*                                 8 (1.8)
  *B. microti / P. vivax*                      1 (0.2)
  *B. microti / P. falciparum*                 1 (0.2)
  *P. vivax*                                  44 (9.8)
  *P. falciparum*                             13 (2.9)
  *P. vivax / P. falciparum*                   5 (1.1)
  *P. malariae*                                1 (0.2)

![**Infection rate of*B. microti*and*Plasmodium*spp. in 449 suspected febrile patients in the area along the China-Myanmar border in the Yunnan province between April 2012 and June 2013.**](2049-9957-2-24-1){#F1}

SSU rRNA sequence and phylogenetic analysis
-------------------------------------------

All the positive samples were sequenced. Sequence identity was confirmed by random basic local alignment search tool analysis of sequences in GenBank (<http://blast.ncbi.nlm.nih.gov/>). Novel sequences were deposited in GenBank with accession nos. KF410824-KF410827. Phylogenetic relationships of unique sequences amplified by using nested primers with corresponding reference sequences were constructed by using the neighbor-joining method using MegAlign software (DNASTAR, Inc. Madison, WI, USA). All sequences clustered with reference sequences of *B. microti* were from different countries or regions, which suggested that all sequences were species specific. Phylogenetic analysis showed that amplified products were species specific (see Figure [2](#F2){ref-type="fig"}).

![**Phylogenetic analysis of 18S small subunit SSU rRNA gene sequences of*B. microti*in the malaria-endemic area along the China-Myanmar border in the Yunnan province, April 2012 to June 2013.** Fragments of 18S SSU rRNA gene sequences of samples were analyzed by aligning with published homologous sequences of *B. microti* from different countries or regions*.* A phylogenetic tree was constructed on the basis of similarities by the MegAlign software (DNASTAR, Inc. Madison, WI, USA). Novel sequences identified in this study are indicated in **boldface**. Scale bar indicates nucleotide substitutions per site.](2049-9957-2-24-2){#F2}

Morphological characteristics
-----------------------------

We observed the intro-erythrocytic cycle of the field samples in Giemsa-stained blood films from individuals that were identified by PCR as having *B. microti* infections. *Babesia* species resemble *P. falciparum*, however, *Babesia* spp. has several distinguishing features: the early trophozoite stage of *B. microti* is smaller than that of *P. falciparum* and the infected erythrocytes are without any pigments. And the late stage of trophozoites is pleomorphic and can be vacuolated. Ring forms of *B. microti* appeared smaller than that of *P. falciparum* and do not produce pigment (see Figure [3](#F3){ref-type="fig"}A), while early trophozoites of *P. falciparum* were larger and malaria pigment was scattered in the infected erythrocytes (see Figure [3](#F3){ref-type="fig"}B). Occasionally, two trophozoites or ring forms would take residence in one erythrocyte (see Figure [3](#F3){ref-type="fig"}C). Tetrads of merozoites that are arranged in a cross-like pattern (a so-called Maltese cross) being pathognomonic for babesiosis can be seen (see Figure [3](#F3){ref-type="fig"}D).

![**Typical morphology of erythrocytic stages of*B. microti*in patients in the area along the China-Myanmar border in the Yunnan province, P.R. China.** Giemsa-stained thin blood films from field samples. **A**: Early trophozoite or ring form of *P. falciparum* and malaria pigment was scattered in the infected erythrocytes. **B**: Ring forms of *B. microti* in one erythrocyte without pigment. **C**: Two ring forms take residents in one erythrocyte **D**: Tetrads of merozoites that are arranged in a cross-like pattern (a so-called Maltese cross).](2049-9957-2-24-3){#F3}

Epidemiological data, clinical history
--------------------------------------

The demographic details of ten babesiosis patients detected by nested PCR from 449 individuals were recalled. All of these individuals were from the aforementioned study area (see Figure [4](#F4){ref-type="fig"}). The brief hospital records and data for clinical presentation, and whether outbound history was available, are shown in Table [2](#T2){ref-type="table"}, but the treatment and outcome was not available. All of the patients were adults and complained of fever with chills and rigor before admission to hospital. We tracked two babesiosis cases as well and found that both of them recalled multiple tick bites in the recent past and also participated in outdoor activities in the mountains. One patient had even received blood transfusion and blood products for treatment of renal-malaria before because of infection of *P. falciparum.*

![Area along the China-Myanmar border in the Yunnan province, P.R. China (which is hilly, and largely covered by primary and secondary rainforests) with babesiosis and malaria.](2049-9957-2-24-4){#F4}

###### 

Demographic and clinical data for patients of babesiosis at dates of admission, in the area along the China-Myanmar border in the Yunnan province, April 2012 to June 2013

  **Demographic data (n = 10)**                 
  --------------------------------------------- ------------------------
  Age (years)                                         32.9 (8.2, 22--45)
  Male gender                                                    6 (60%)
  Adults (\>18 years)                                          10 (100%)
  Clinical history and presentations (n = 10)   
  Temperature at admission (°C)                   37.8 (0.82, 36.0-38.8)
  Outbound history                                               6 (60%)
  Duration of illness before admission (days)           6.2 (9.4, 1--32)
  Fever, chill, and rigor                                      10 (100%)

Data shown as n (% of total), or mean (SD; range) unless otherwise stated.

Discussion
==========

Between 1931 and 1944, Hung S.L. *et al.*\[[@B26]\] reported several human parasitemia in Chongqing, China, on protozoa taking residents in human erythrocytes, which was described as being similar to *P. falciparum*, but with fundamental differences of smaller ring forms and no pigments, and so it clearly indicated that it was *Babesia* spp. infection. These reports came 13 years earlier than the first case of human babesiosis was reported in a Yugoslavian farmer in 1957 \[[@B1]\], and strongly suggested that human *Babesia* spp. infection may have already existed widely in P.R. China. In fact, Yunnan, Inner Mongolia, Taiwan and Zhejiang, and other regions in P.R. China also have sporadic human babesiosis cases reported from 1984 to 2012 \[[@B5],[@B8],[@B27]-[@B30]\]. Sun Y *et al.*\[[@B31]\] reported that a *B. microti*-like rodent parasite was isolated from the tick, *I. persulcatus*, collected from the northern forest area of Heilongjiang province, P.R. China. Saito-Ito *et al.*\[[@B32]\] confirmed *Babesia* spp. infection of the Kobe strain presented in rodents in Zhejiang, Fujian, and Taiwan. But there are no reports of regional popularity on human babesiosis especilly in these natural foci areas in which *Babesia spp.* existed in the ticks or/and other reservoir hosts. Our study supports the hypothesis that human babesiosis caused by *B. microti* infection is emerging in areas along the China-Myanmar border in counties such as Tengchong in the Yunnan province, P.R. China, but can be ignored because of mix infection with *Plasmodium* spp. or low parasitemia.

Both *Plasmodium* and *Babesia* species are intraerythrocytic protozoans and they elicit similar inflammatory responses and clinical manifestations that differ markedly in severity. *Babesia* spp. co-infection with *P. falciparum* could not be ruled out in one case. The possibility of co-infection with babesial and malarial agents was well described in an infant from the Ivory Coast who was quite ill with parasitaemia of 35% \[[@B33]\]. Co-infection with both agents was reported in another rhesus monkey imported from Guangxi, P.R. China and the suspected infection of *B. microti*-like originated from primate-breeding facility \[[@B34]\]. Here, we detected two cases of febrile patients who were co-infected with *Plasmodium* spp. and *Babesia* spp. in malaria endemic area by molecular survey -- it was unclear what the dominant parasite was and the microscopy detection of the parasite species of co-infections cases seem more difficult. It was reported that a rhesus monkey that was chronically infected with *B. microti* was able to control infection with *P. cynomolgi* better than naïve monkeys \[[@B35]\]. The suppression of *Plasmodium* spp. infection after chronic exposure to *B. microti* also warrants further investigation of a possible protective role of *Babesia* spp. infection on *Plasmodium spp*.

The new finding of mono-infection of *Babesia* and co-infection of *Babesia* spp. and *Plasmodium* spp. in the malaria-endemic area of the Tengchong county would bring new challenges to the prevention and controlling of these infectious diseases. It must also be noted that most antimalarial drugs, such as chloroquine, mefloquine, and artemisinin, have no effect on babesiosis \[[@B36]\]. Quinine and clindamycin, the former of which is often used for treatment of drug-resistant malaria, are the first-choice drugs against babesiosis \[[@B4],[@B37]\]. Therefore, babesiosis in areas in which malaria is endemic might be misdiagnosed as drug-resistant malaria. From this standpoint, the identification of babesial parasite infection in the Yunnan province, where malaria is endemic, seems to deserve attention, considering that recent Asian cases of human babesiosis emerged in P. R. China and Japan, where *B. microti*-like parasites had earlier been identified in rodents. The importance of this finding in human co-infection of *Babesia* spp. and *Plasmodium* spp. is also reflected in case therapy as treatment of malaria patients depends on correct diagnosis of parasite species \[[@B38]\]. Ring forms of *Babesia spp.* may resemble those of *P. falciparum*\[[@B9]\]. Artemisinin-based combination therapies are the recommended first-line treatments of *falciparum* malaria in all countries where malaria transmitted. There are recent concerns that the efficacy of such therapies has declined on the Thailand-Cambodian and Thailand-Myanmar borders, historically sites of emerging antimalarial-drug resistance \[[@B39],[@B40]\]. The morphology of *P. falciparum* and *B. microti* are similar especially in the ring form stage which is the main intraerythrocyte of both parasites so human Babesiosis may be misdiagnosed as *falciparum* malaria in these malaria endemic areas. Giving Artemisinin-based combination therapies to these babesiosis patients due to misdiagnosis would undoubtedly increase the pressure of artemisinin resistance in malaria-transmitted areas.

Conclusions
===========

Babesiosis has sometimes been diagnosed initially as malaria because of the similarity between the two diseases, which is the main reason why it is difficult to detect it in co-infections \[[@B41]\]. This report supports the hypothesis that babesiosis caused by *B. microti* is emerging along the China-Myanmar border in the Yunnan province, P.R. China, but it was ignored because of low parasitemia or mixed infection with *Plasmodium* spp. It's crucial to apply more sensitive and specific diagnosis methods to set up rapid response mechanisms of emergency for the important infectious diseases in babesiosis and malaria syndemic areas, particularly in places which are weak in surveillance and response systems \[[@B42]\].
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